Molecular Dynamics Simulations of the HIV-1 Integrase Dimerization Interface: Guidelines for the Design of a Novel Class of Integrase Inhibitors

被引:11
|
作者
Sippel, Martin [1 ]
Sotriffer, Christoph A. [1 ]
机构
[1] Julius Maximilians Univ Wuerzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany
关键词
PROTEIN-PROTEIN INTERACTIONS; VIRUS TYPE-1 INTEGRASE; PEPTIDE INHIBITORS; AUTOMATED DOCKING; GENETIC ALGORITHM; SCORING FUNCTION; BINDING MODES; LIGAND; DISCOVERY; RALTEGRAVIR;
D O I
10.1021/ci900403s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
HIV-1 integrase (IN) is a validated target of anti-AIDS research. The classical approach of designing active-site directed ligands has largely been exploited. A promising alternative strategy to inactivate the enzyme is to prevent the formation of IN dimers. The rational design of dimerization inhibitors, however, is hampered by the lack of relevant structural data about the targeted monomeric form. Therefore, we performed molecular dynamics simulations and subsequent analyses to gain insight into the structural features of the IN catalytic-core-domain dimerization interface. As a result, the formation of a groove and a cavity along the dimerization interface of the IN monomer could be revealed. Both were shown to be suited for accommodating an inhibitory peptide. The results form a valuable basis for the design of ligands targeting the dimerization interface and, thus, of a whole new class of HIV-1 integrase inhibitors.
引用
收藏
页码:604 / 614
页数:11
相关论文
共 50 条
  • [1] Evolution of a novel class of HIV-1 integrase inhibitors
    Gomez, RP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U123 - U123
  • [2] Discovery of small molecule HIV-1 integrase dimerization inhibitors
    Tintori, Cristina
    Demeulemeester, Jonas
    Franchi, Luigi
    Massa, Silvio
    Debyser, Zeger
    Christ, Frauke
    Botta, Maurizio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) : 3109 - 3114
  • [3] Discovery of novel HIV-1 integrase inhibitors
    Hong, HX
    Neamati, N
    Wang, SM
    Nicklaus, M
    Pommier, Y
    Milne, GWA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 22 - MEDI
  • [4] Design and discovery of HIV-1 integrase inhibitors
    Neamati, N
    Sunder, S
    Pommier, Y
    DRUG DISCOVERY TODAY, 1997, 2 (11) : 487 - 498
  • [5] Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization
    Zhao, L
    Chmielewski, JA
    BIOPOLYMERS, 2003, 71 (03) : 397 - 397
  • [6] Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization
    Zhao, L
    O'Reilly, MK
    Shultz, MD
    Chmielewski, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1175 - 1177
  • [7] An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors
    Wilson, Tyler A.
    Koneru, Pratibha C.
    Rebensburg, Stephanie V.
    Lindenberger, Jared J.
    Kobe, Matthew J.
    Cockroft, Nicholas T.
    Adu-Arnpratwum, Daniel
    Larue, Ross C.
    Kvaratskhelia, Mamuka
    Fuchs, James R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (02): : 215 - 220
  • [8] Methylenebysphosphonates as new class of HIV-1 integrase inhibitors
    Anisenko, A.
    Agapkina, J.
    Korolev, S.
    Yanvarev, D.
    Kochetkov, S.
    Gottikh, M.
    FEBS JOURNAL, 2013, 280 : 365 - 366
  • [9] Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors
    Yu, Shenghui
    Sanchez, Tino Wilson
    Liu, Yang
    Yin, Yanzhen
    Neamati, Nouri
    Zhao, Guisen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (22) : 6134 - 6137
  • [10] Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors
    Hu, Liming
    Zhang, Sulei
    He, Xianzhuo
    Luo, Zaigang
    Wang, Xiaoli
    Liu, Wei
    Qin, Xuemei
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (01) : 177 - 182